arrow
F

Fernando S. Goes

Johns Hopkins School of Medicine
H指数:67
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolomic correlates of intravenous racemic ketamine in treatment-resistant major depressive disorder: the Bio-K/NNDC multicenter trial

静脉注射外消旋氯胺酮在治疗难治性重度抑郁症中的代谢组学相关性:Bio-K/NNDC多中心试验

2026-09-060
PRE
Establishing a Specialty Bipolar Clinic: The National Network of Depression Centers Consensus Recommendations

建立专科双相情感障碍诊所:国家抑郁症中心网络共识建议

2026-08-170
OAAI
A Study of Alcohol Dependence in Obsessive-Compulsive Disorder

强迫症中酒精依赖的研究

2026-04-060
PRE
Comparing the Cognitive Effects of Repeated Intravenous Ketamine and Electroconvulsive Therapy in Patients With Treatment-Resistant Depression: A Secondary Analysis of the ELEKT-D Trial

比较重复静脉注射氯胺酮与电休克疗法在治疗难治性抑郁症患者中的认知效应:ELEKT-D试验的二次分析

2025-12-010
PRE
Moving beyond symptom subtypes: testing a common dimension of lifetime OCD symptoms

超越症状亚型: 测试终生强迫症症状的共同维度

2025-11-030
OAAI
Clinical outcomes of youth at familial risk for bipolar disorder: A 2-year longitudinal, observational study

家族性双相障碍风险青少年的临床结局:一项为期2年的纵向观察性研究

2025-10-150
OAAI
Considerations in the development of learning health networks for mood disorders

心境障碍学习健康网络的发展考量

2025-07-110
PRE
Pathway-Specific Polygenic Scores for Lithium Response for Predicting Clinical Lithium Treatment Response in Patients with Bipolar Disorder

锂反应的通路特异性多基因评分,用于预测双相障碍患者临床锂治疗反应

2025-06-250
OAAI
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant Depression

高基线血浆邻氨基苯甲酸预测急性系列氯胺酮输注对难治性抑郁症的缓解

2025-04-120
OA
Trends in mental health care and telehealth use across area deprivation: An analysis of electronic health records from 2016 to 2024

精神卫生保健和远程医疗使用趋势与区域剥夺程度的关系:基于2016年至2024年电子健康记录的分析

2025-02-070
OA
Gaps in psychiatric care before and after the COVID-19 pandemic among patients with depression using electronic health records

使用电子健康记录的抑郁症患者在新型冠状病毒肺炎大流行前后的精神病护理差距

2025-02-010
PRE